Skip to main content
Figure 5 | Breast Cancer Research

Figure 5

From: c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study

Figure 5

Survival of patients with and without overexpression of c-erbB2 and topoisomerase IIα. The difference between patients without overexpression of c-erbB2 or topoisomerase (broken line), patients with tumors overexpressing one of the two proteins (c-erbB2, dot–dashed line; topoisomerase IIα, solid line), and patients with tumors overexpressing both c-erbB2 and topoisomerase IIα (dotted line) was significant (log rank 29.71; P < 0.0001).

Back to article page